If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksImperial Innovations Group Regulatory News (IVO)

  • There is currently no data for IVO

Directorate Change

23 Jul 2015 13:35

RNS Number : 9253T
Imperial Innovations Group plc
23 July 2015
 



23 July 2015

 

Imperial Innovations Group plc

 

Directorate Change

 

Imperial Innovations Group plc (AIM: IVO, 'the Group', 'Innovations') announces that its non-executive director Mark Rowan will resign from the Board on 31 July 2015.

 

Mark was appointed to the Board in April 2006, having been a director of the Group's subsidiary Imperial Innovations Ltd since January 2005. He joined Innovations after a career working at J.P. Morgan and American International Group and has also provided advice on strategic and structural issues to a broad spectrum of companies, including early-stage technology investments.

 

Mark served as the Chairman of the Group's Audit and Risk Committee since the Group's IPO in 2006. He also served on the Remuneration Committee and Nomination Committee.

 

Linda Wilding takes over as chair of the Audit and Risk Committee on 1 August 2015.

 

Martin Knight, Chairman of Imperial Innovations, said:

 

"On behalf of the Board I would like to thank Mark for more than ten years of service to the Group, during which time we have benefited from his extensive experience, wise counsel and financial expertise.

 

"He has played an important role in Innovations' evolution, from its IPO in 2006, to its current position as one of the UK's leading technology commercialisation companies.

 

"His legacy includes our sound financial controls and funding strategy, recent highlights of which include the execution of last year's £150m placing and obtaining £80m in loan facilities from the European Investment Bank (EIB).

 

"Mark has made a significant contribution to the success of the Group and we would all like to thank him for his service and offer him our best wishes for the future."

 

For further information contact:

 

Imperial Innovations Group plc

020 3053 8834

Martin Knight, Chairman

Jon Davies, Director of Communications

 

Instinctif Partners

020 7457 2020

Adrian Duffield/Melanie Toyne-Sewell

 

J.P. Morgan Cazenove (Nominated Adviser)

020 7742 4000

Michael Wentworth-Stanley/Alec Pratt

 

Cenkos Securities

020 7397 8900

Christopher Golden

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAPGUCWMUPAGPW
Date   Source Headline
24th Jan 20117:00 amRNSResult of equity raise
6th Jan 20111:11 pmRNSResult of General Meeting
9th Dec 201011:10 amRNSDirectors' Dealings
8th Dec 20104:55 pmRNSPublication of Prospectus
7th Dec 20107:09 amRNS£140m equity raising
12th Oct 20107:00 amRNSFinal Results
15th Sep 20104:17 pmRNSNotice of Results
2nd Sep 20109:00 amRNSPortfolio News
25th Aug 20109:00 amRNSPortfolio Company News
20th Aug 20109:00 amRNSFurther portfolio investments
22nd Jun 201010:37 amRNSDirectors' Dealings
1st Jun 20107:01 amRNSSale of portfolio company
27th Apr 20107:00 amRNSInterim Results
23rd Apr 20109:05 amRNSMIT praises Novacem technology
9th Apr 20107:00 amRNSNotice of Results
6th Apr 20108:00 amRNSInvestment in portfolio company
11th Mar 20108:00 amRNSFurther Investment in portfolio company
8th Mar 20104:19 pmRNSChange of Adviser
5th Mar 201011:05 amRNSTR1 - Notification of major interest in shares
3rd Mar 20108:30 amRNSMilestone for Nexeon
2nd Mar 20107:16 amRNSMembrane Extraction Technology sold
1st Mar 20107:00 amRNSInvestment in portfolio company
17th Feb 20107:00 amRNSFurther Investment In PolyTherics
8th Feb 201012:41 pmRNSDirector Dealing
5th Feb 20103:42 pmRNSNotification of Major Interest in Shares
27th Jan 20107:00 amRNSLicence Agreement
19th Jan 20105:58 pmRNSDirector Dealings
19th Jan 201011:47 amRNSAdditional Listing of Shares
21st Dec 200911:32 amRNSBoard Appointment
15th Dec 200912:04 pmRNSResult of AGM
11th Dec 20097:00 amRNSFurther investment in portfolio company
8th Dec 200910:14 amRNSDirector Dealing's
27th Nov 200910:31 amRNSHolding(s) in Company
11th Nov 200911:42 amRNSNotice of AGM
21st Oct 20093:20 pmRNSDirector Dealings
20th Oct 20097:00 amRNSFurther Investment In Portfolio Company
13th Oct 20094:17 pmRNSDirector Dealing
12th Oct 20093:09 pmRNSDirectors' Dealings
8th Oct 20097:00 amRNSFurther Investment in Plaxica
7th Oct 20097:00 amRNSFinal Results
21st Sep 20097:00 amRNSInvestment in Portfolio Company
1st Sep 20097:00 amRNSLeads ?2 funding round in Molecular Vision
25th Aug 20093:30 pmRNSNotice of Results
10th Aug 20097:00 amRNSInvestments in portfolio companies
3rd Jul 20097:00 amRNSInvestment in OSspray
26th Jun 20097:00 amRNSDisposal of investment in InforSense
2nd Jun 20094:30 pmPRNHolding(s) in Company
28th May 20098:05 amRNSPortfolio Company IP Trade Sale to Technip
20th May 20097:00 amRNSDirector/PDMR Shareholding
27th Apr 20097:00 amPRNHalf-yearly Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.